AMSTERDAM--(BUSINESS WIRE)--Genmed Holding Corp. (OTCBB: GENM) released data today on the size and scope of the European Union’s generic drug market. The countries of Western Europe represent a total market of over 365 million people and a combined GDP of over US$14.4 trillion. Major expansion of generic pharmaceutical sales is expected in EU countries such as Germany, France, the United Kingdom, Italy and Austria.
